Table 1.
Summary of physical and clinical characteristics and daily activity of study cohort.
| Baseline (BL) | Step Reduction (SR) | Recovery (RC) | p-Value* | |
|---|---|---|---|---|
| Sex | 10 male, 7 female | - | - | |
| Age (years) | 69 ± 4 | - | - | |
| Body Mass (kg) | 75 ± 14 | 76 ± 15 | 76 ± 15 | 0.26 |
| BMI (kg∙m2) | 27 ± 4 | 27 ± 4 | 27 ± 4 | 0.16 |
| Daily Energy Expenditure (kJ) | 9890 ± 2680 | 8118 ± 1350 | 9498 ± 2310 | 2.99 × 10−4 |
| Myofibrillar Protein Synthesis (% per day) | 1.50 ± 0.06 | 1.33 ± 0.05 | 1.32 ± 0.14 | 0.040 |
| Pedometer Steps (per day) | 7550 ± 3320 | 980 ± 84 | 7345 ± 3850 | 2.70 × 10−6 |
| Armband steps (per day) | 6375 ± 3560 | 1248 ± 850 | 5612 ± 3740 | 1.33 × 10−4 |
| Fasting glucose (mM) | 5.24 ± 0.61 | 5.31 ± 0.92 | 5.47 ± 0.73 | 0.26 |
| (mg/dL) | 94 ± 11 | 96 ± 17 | 99 ± 13 | 0.26 |
| 2h Post-OGTT glucose (mM) | 7.6 ± 1.5 | 9.0 ± 2.4 | 8.2 ± 2.9 | 0.070 |
| (mg/dL) | 137 ± 26 | 163 ± 43 | 147 ± 53 | 0.070 |
* p-values determined using a one-way repeated measures ANOVA.